Antibiotics for Furuncle
For simple, uncomplicated furuncles, incision and drainage alone is the primary treatment and antibiotics are generally not necessary. 1
When to Prescribe Antibiotics
Add antibiotic therapy when furuncles are associated with any of the following conditions: 2, 1
- Severe or extensive disease (multiple sites of infection)
- Rapid progression with associated cellulitis
- Systemic signs of illness (fever, tachycardia, elevated WBC)
- Comorbidities or immunosuppression
- Extremes of age (very young or elderly)
- Difficult-to-drain locations (face, hand, genitalia)
- Associated septic phlebitis
- Failure to respond to incision and drainage alone
Oral Antibiotic Options
For MRSA Coverage (Community-Acquired MRSA)
First-line oral agents for empirical CA-MRSA coverage include: 1
- Clindamycin 300-450 mg three times daily (A-I evidence)
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily (A-II evidence)
- Doxycycline or minocycline 100 mg twice daily (A-II evidence)
- Linezolid 600 mg twice daily (A-II evidence)
Important caveats:
- Clindamycin resistance is increasingly common in some regions; check local resistance patterns 3
- TMP-SMX lacks reliable streptococcal coverage
- Tetracyclines should not be used in children <8 years of age 1
- Minocycline may be more reliable than doxycycline or TMP-SMX when these agents fail 4
For MSSA Coverage
If MSSA is confirmed or suspected (and MRSA ruled out): 5
- Dicloxacillin 500 mg four times daily (oral agent of choice)
- Cephalexin 500 mg four times daily
- Clindamycin 300-450 mg three times daily (if penicillin allergic)
Dual Coverage Strategy
If coverage for both streptococci and MRSA is needed: 1
- Clindamycin alone (covers both), OR
- TMP-SMX or tetracycline PLUS a β-lactam (e.g., amoxicillin), OR
- Linezolid alone (covers both)
Duration of Therapy
Treat for 5-10 days, individualized based on clinical response. 2, 1 For patients with multiple furuncles or systemic involvement, longer courses may be necessary 6.
Culture Recommendations
Obtain cultures from purulent drainage when: 1, 3
- Antibiotics are being prescribed
- Severe local infection or systemic illness present
- Patient has not responded to initial treatment
- Concern for outbreak or cluster of cases
Common Pitfalls
- Do not use rifampin as single agent or adjunctive therapy for skin infections 1
- Avoid relying solely on incision and drainage when systemic features or high-risk conditions are present
- Consider local MRSA prevalence when choosing empirical therapy—CA-MRSA is now endemic in many U.S. communities 7
- Be aware that in vitro susceptibilities don't always predict clinical effectiveness for MRSA 4